Steris plc to host Q2FY27 earnings conference call on Nov 5

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Steris plc will host a conference call for Q2FY27 results on November 5, 2026
  • Financial press release to be issued after market close on November 4, 2026
  • Replay available from 12:00 pm ET on November 5, 2026
powered bylight_fuzz_icon
54074526

*this image is generated using AI for illustrative purposes only.

Steris plc announced it will host a conference call to discuss its fiscal 2027 second quarter results at 9:00 am ET on November 5, 2026. The event provides investors with insights into the company's recent performance and strategic updates.

A press release detailing the financial results will be issued after the U.S. market closes on November 4, 2026. This timing allows market participants to digest the data before the live discussion begins.

Accessing the Conference Call

The conference call can be heard live at www.steris-ir.com or via phone. Participants in the United States can dial 1-833-535-2199, while international callers should use 1-412-902-6776. Attendees must ask to join the conference call for Steris plc.

For those unable to listen live, a replay will be available beginning at 12:00 pm ET on November 5, 2026. The replay can be accessed at www.steris-ir.com or via phone using access code 2589658. United States numbers are 1-855-669-9658 and international numbers are 1-412-317-0088.

Company Profile

Steris is a leading global provider of products and services that support patient care with an emphasis on infection prevention. The company delivers innovative healthcare and life science products and services around the globe.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might Steris's Q2 FY2027 results influence its guidance for the remainder of the fiscal year?

What specific trends in infection prevention demand are expected to be highlighted during the conference call?

Will Steris announce any new strategic partnerships or acquisitions alongside its financial results?

STERIS CEO Dan Carestio to present at Morgan Stanley Healthcare Conference

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • STERIS CEO Dan Carestio to present at Morgan Stanley Healthcare Conference
  • Presentation scheduled for September 15, 2026, at 1:05 pm ET in New York
  • Webcast and replay available on investor relations website
powered bylight_fuzz_icon
49840606

*this image is generated using AI for illustrative purposes only.

STERIS plc (NYSE: STE) announced that President and CEO Dan Carestio will present at the Morgan Stanley Healthcare Conference in New York City on September 15, 2026.

The presentation is scheduled for 1:05 pm Eastern Time. A simultaneous webcast and replay will be available on the company’s investor relations website.

Conference Details

  • Event: Morgan Stanley Healthcare Conference
  • Date: September 15, 2026
  • Time: 1:05 pm Eastern Time
  • Location: New York City
  • Speaker: Dan Carestio, President and CEO

About STERIS

STERIS is a global provider of products and services supporting patient care, with an emphasis on infection prevention. The company provides innovative healthcare and life science products and services worldwide.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific strategic initiatives or financial guidance might CEO Dan Carestio unveil regarding STERIS's infection prevention portfolio at the upcoming conference?

How could the presentation influence STERIS's stock valuation and investor sentiment in the days following the September 15 event?

Are there indications that STERIS is planning any new mergers, acquisitions, or partnerships to expand its global healthcare services footprint?

More News on Steris